Cidara Therapeutics
CDTX
CDTX
60 hedge funds and large institutions have $54.8M invested in Cidara Therapeutics in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.39% less ownership
Funds ownership: 3.69% → 3.3% (-0.39%)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
46% less capital invested
Capital invested by funds: $102M → $54.8M (-$46.7M)
Holders
60
Holding in Top 10
3
Calls
$867K
Puts
$15K
Top Buyers
| 1 | +$1.42M | |
| 2 | +$725K | |
| 3 | +$483K | |
| 4 |
Goldman Sachs
New York
|
+$409K |
| 5 |
Renaissance Technologies
New York
|
+$330K |
Top Sellers
| 1 | -$5.44M | |
| 2 | -$1.93M | |
| 3 | -$1.87M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.85M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.17M |